canin
respiratori
coronaviru
crcov
identifi
member
coronavirida
famili
viru
betacoronaviru
close
rel
human
coronaviru
bovin
coronaviru
examin
entri
crcov
human
rectal
tumor
cell
cell
line
analyz
coloc
singl
viru
particl
cellular
marker
presenc
absenc
chemic
inhibitor
pathway
potenti
involv
viru
entri
also
target
pathway
use
sirna
result
show
viru
hijack
caveolindepend
endocytosi
enter
cell
via
endocyt
intern
author
articl
distribut
term
creativ
common
attribut
intern
licens
http
creat
iveco
mmon
orglicen
permit
unrestrict
use
distribut
reproduct
medium
provid
give
appropri
credit
origin
author
sourc
provid
link
creativ
common
licens
indic
chang
made
creativ
common
public
domain
dedic
waiver
coronavirus
envelop
singlestrand
positivesens
rna
virus
belong
famili
coronavirida
within
order
nidoviral
base
properti
famili
divid
four
distinct
genu
alpha
beta
delta
gamma
coronavirus
infect
wide
varieti
bird
mammal
includ
human
livestock
companion
anim
human
coronavirus
hcov
associ
mainli
rel
mild
upper
lower
respiratori
tract
diseas
howev
emerg
sever
acut
respiratori
syndrom
coronaviru
sarscov
winter
china
recent
middl
east
respiratori
syndrom
coronaviru
merscov
middl
east
demonstr
potenti
threat
pose
zoonot
coronavirus
canin
respiratori
coronaviru
crcov
first
identifi
sampl
obtain
respiratori
tract
dog
canin
infecti
respiratori
diseas
cird
also
known
kennel
cough
hous
anim
shelter
unit
kingdom
cird
contagi
diseas
high
morbid
low
mortal
usual
occur
dens
hous
dog
popul
eg
rehom
center
veterinari
hospit
character
dri
hack
cough
diseas
gener
mild
selflimit
howev
progress
potenti
fatal
bronchopneumonia
cird
consid
complex
infect
multifactori
etiolog
number
organ
includ
bordetella
bronchiseptica
canin
parainfluenza
viru
canin
adenoviru
type
canin
herpesviru
mycoplasma
spp
canin
pneumoviru
influenza
virus
involv
believ
crcov
play
role
earli
stage
cird
limit
ciliari
clearanc
upper
airway
consequ
infect
lead
reduc
respiratori
clearanc
sensit
secondari
infect
crcov
close
relat
two
betacoronavirus
bovin
coronaviru
bcov
nucleotid
ident
spike
gene
bcov
report
erl
et
al
clearli
distinct
canin
enter
coronaviru
cecov
previous
known
canin
coronaviru
crcov
difficult
pathogen
work
confirm
suscept
cell
line
human
rectal
tumor
cell
line
deriv
canin
cell
line
support
replic
viru
furthermor
crcov
produc
cytopath
effect
cell
initi
infect
envelop
virus
fuse
host
cell
membran
prior
deliv
genet
materi
process
may
occur
cell
surfac
eg
human
immunodefici
viru
herp
simplex
viru
otherwis
prior
intern
requir
enter
cell
virus
hijack
number
differ
endocyt
pathway
includ
macropinocytosi
clathrinmedi
caveolinmedi
clathrinand
caveolinindepend
rout
exampl
sarscov
use
clathrindepend
lipid
raftmedi
clathrinand
caveolaeindepend
entri
pathway
addit
felin
infecti
periton
viru
fipv
use
clathrinand
caveolinindepend
endocyt
rout
wherea
use
caveolaedepend
endocytosi
furthermor
human
respiratori
coronavirus
may
util
proteas
activ
modul
rout
entri
gener
within
endocyt
pathway
vesicl
form
interact
certain
protein
network
earli
vesicl
provid
start
point
traffick
lead
endosom
matur
allow
sort
incom
cargo
intern
vesicl
recycl
back
cell
surfac
other
convert
exampl
lysosom
sort
cargo
regul
rab
gtpase
serv
molecular
hallmark
differ
rout
studi
intern
crcov
cell
result
clearli
demonstr
crcov
entri
cell
requir
endocyt
intern
prior
membran
fusion
process
requir
dynamin
furthermor
fusion
viral
cellular
membran
occur
endosom
progress
late
phase
atcc
cell
deriv
atcc
ileocec
colorect
adenocarcinoma
maintain
dulbecco
mem
life
technolog
poland
supplement
heatinactiv
fetal
bovin
serum
life
technolog
penicillin
uml
streptomycin
ciprofloxacin
cell
cultur
co
viru
stock
canin
respiratori
coronaviru
strain
prepar
infect
cell
monolay
collect
supernat
day
postinfect
pi
obtain
stock
aliquot
store
control
mockinfect
cell
prepar
manner
viru
yield
estim
titrat
confluent
cell
accord
method
reed
muench
cpe
visibl
cell
infect
day
fix
immunostain
detect
virusinfect
cell
coloc
studi
stock
concentr
use
amicon
ultra
centrifug
filter
merck
cutoff
aliquot
store
dmem
supplement
uml
penicillin
ml
streptomycin
one
follow
chemic
inhibitor
amtd
sigmaaldrich
poland
pitstop
abcam
chlorpromazin
sigmaaldrich
filipin
iii
sigmaaldrich
nystatin
sigmaaldrich
mm
sigmaaldrich
cell
pretreat
chemic
inhibitor
h
full
list
addit
file
expos
viru
tissu
cultur
infecti
dose
tcid
presenc
inhibitor
two
hour
pi
cell
wash
pb
twice
remov
unbound
viru
medium
fresh
inhibitor
ad
well
five
day
pi
cell
harvest
analysi
cell
viabil
test
day
five
pi
use
xtt
base
cell
prolifer
kit
biolog
industri
accord
manufactur
instruct
cell
treat
inhibitor
harvest
day
pi
trypsin
centrifug
min
g
wash
pb
fix
formalin
pb
min
room
temperatur
rt
permeabil
triton
pb
min
rt
bioshop
unspecif
bind
site
block
bovin
serum
albumin
bsa
bioshop
pb
h
rt
prior
stain
cell
incub
anticoronaviru
antibodi
strain
ml
merck
h
secondari
alexa
fluor
goat
antimous
antibodi
thermo
scientif
poland
h
cell
wash
resuspend
pb
analyz
flow
cytometri
facscalibur
becton
dickinson
cell
cultur
coverslip
plate
h
wash
icecold
pb
incub
concentr
crcov
min
subsequ
incub
min
coverslip
wash
thrice
pb
fix
formalin
min
permeabil
bioshop
min
unless
state
otherwis
unspecif
bind
site
block
use
bsa
pb
overnight
prior
stain
visual
crcov
particl
anticoronaviru
antibodi
strain
h
rt
merck
coupl
goat
antimous
alexa
fluor
antibodi
ml
h
rt
thermo
scientif
use
visual
host
cell
protein
cell
block
use
fb
pb
overnight
incub
h
rt
one
follow
antibodi
antibodi
ml
santa
cruz
biotechnolog
clathrin
hc
antibodi
santa
cruz
biotechnolog
antibodi
santa
cruz
biotechnolog
rab
antibodi
santa
cruz
biotechnolog
endophilin
antibodi
santa
cruz
biotechnolog
rab
antibodi
proteintech
lamp
antibodi
thermo
scientif
coupl
secondari
goat
antirabbit
alexa
fluor
thermo
scientif
signal
specif
verifi
use
isotyp
control
normal
rabbit
igg
normal
goat
igg
santa
cruz
biotechnolog
follow
cell
wash
thrice
pb
nuclear
dna
stain
dapi
sigmaaldrich
stain
coverslip
mount
glass
slide
prolong
diamond
medium
thermo
scientif
fluoresc
imag
acquir
use
zeiss
lsm
confoc
microscop
carl
zeiss
microscopi
gmbh
cell
pretreat
chemic
inhibitor
incub
concentr
crcov
presenc
inhibitor
h
two
hour
pi
cell
wash
pb
twice
remov
unbound
viru
fix
formalin
pb
min
rt
permeabil
unspecif
bind
site
block
use
bsa
pb
overnight
prior
stain
crcov
visual
use
anticoronaviru
antibodi
strain
h
rt
merck
coupl
goat
antimous
alexa
fluor
antibodi
h
rt
thermo
scientif
studi
alexafluor
phalloidin
uml
h
rt
thermo
scientif
label
actin
cortex
assum
indic
cell
surfac
nuclear
dna
stain
dapi
sigmaaldrich
coverslip
mount
glass
slide
prolong
diamond
medium
cell
infect
crcov
tcid
h
incub
unbound
viru
wash
pb
cell
overlaid
cultur
medium
contain
chemic
inhibitor
five
day
pi
cell
harvest
analysi
cell
infect
crcov
tcid
h
incub
unbound
viru
wash
pb
cell
overlaid
cultur
medium
contain
decanoylrvkrchloromethyl
keton
decrvkrcmk
four
day
pi
cell
fix
stain
fluoresc
imag
acquir
cell
transfect
pmol
sirna
santa
cruz
biotechnolog
scrambl
neg
control
sirna
santa
cruz
biotechnolog
use
lipofectamin
rnaimax
reagent
thermo
scientif
accord
manufactur
protocol
two
consecut
transfect
perform
h
h
cell
seed
subsequ
cell
infect
prepar
imag
graph
present
work
creat
use
graphpad
prism
softwar
signific
estim
use
oneway
anova
multipl
comparison
viru
control
imag
obtain
confoc
microscop
deconvolv
use
autoqu
process
imagej
fiji
coloc
analys
perform
imagej
use
jacop
plugin
pearson
mander
coeffici
calcul
cell
reconstruct
bioinformat
analysi
conduct
use
arginin
lysin
propeptid
cleavag
site
predict
algorithm
prop
server
use
follow
sequenc
data
isol
isol
strain
strain
strain
strain
weak
base
nh
cl
previous
describ
hamper
endosom
entri
virus
prevent
phdepend
activ
fusion
protein
subsequ
block
membran
fusion
treatment
cell
mm
nh
cl
inhibit
replic
crcov
control
addit
file
inhibit
viru
entri
host
cell
figur
b
bafilomycin
inhibit
vacuolar
h
atpas
block
endosom
acidif
similarli
bafilomycin
block
viru
replic
reduct
number
infect
cell
compar
control
addit
file
viru
entri
figur
b
surprisingli
addit
bafilomycin
nh
cl
h
pi
also
result
decreas
viru
replic
similar
observ
made
test
inhibitor
intracellular
traffick
addit
file
reason
decid
use
analysi
data
viru
entri
consequ
test
whether
viru
enter
cell
endocytosi
examin
coloc
viral
particl
earli
endosom
antigen
differ
time
postinfect
pi
coloc
clearli
visibl
figur
peak
min
pi
mander
coeffici
min
min
pi
coloc
late
endosom
marker
rab
lysosom
marker
endosom
marker
rab
visibl
time
addit
file
obtain
result
suggest
crcov
undergo
fusion
alreadi
earli
endosom
compart
may
seem
contradictori
previou
report
howev
virus
process
furin
produc
cell
make
process
cathepsin
dispens
silico
analysi
predict
potenti
furin
cleavag
site
crcov
spike
glycoprotein
gene
addit
file
effect
decrvkrcmk
santa
cruz
biotechnolog
viru
replic
well
celltocel
spread
test
visibl
figur
alter
viru
entri
observ
next
use
inhibitor
endocytosi
examin
endocyt
pathway
util
crcov
enter
cell
inhibitor
use
highest
nontox
concentr
determin
xtt
assay
data
shown
valid
obtain
data
verifi
use
posit
control
transferrin
cholera
toxin
subunit
b
cht
x
b
dextran
enter
cell
via
clathrindepend
pathway
caveolindepend
pathway
macropinocytosi
respect
determin
whether
crcov
enter
cell
clathrinmedi
endocytosi
cme
treat
cell
chlorpromazin
amantadin
none
compound
affect
viru
entri
cell
figur
b
caveola
rich
cholesterol
sphingolipid
disrupt
sterolbind
agent
nystatin
filipin
filipin
effect
viru
entri
neither
hamper
intern
cht
x
b
impli
ineffect
inhibitor
cell
line
nystatin
block
viru
intern
cell
figur
b
suggest
caveola
essenti
crcov
intern
ensur
observ
effect
artifact
express
silenc
use
sirna
shown
figur
deplet
result
reduct
number
viru
particl
enter
cell
check
whether
viru
enter
cell
via
macropinocytosi
treat
na
h
exchang
inhibitor
eipa
inhibitor
inhibitor
wortmannin
effect
viru
entri
howev
observ
figur
b
result
show
compound
interfer
caveosom
format
affect
crcov
entri
howev
report
show
compound
offtarget
multitarget
activ
therefor
ensur
valid
obtain
data
examin
coloc
viru
particl
marker
differ
endocyt
pathway
cell
expos
viru
min
shown
figur
crcov
coloc
caveolin
min
pi
maintain
min
pi
visual
assess
analysi
coloc
coeffici
reveal
coloc
mark
cht
x
b
util
mediat
pathway
enter
cell
figur
also
examin
whether
viru
coloc
clathrin
figur
endophilin
addit
file
coloc
detect
dynamin
essenti
sever
endocyt
pathway
therefor
ask
whether
gtpase
play
role
crcov
entri
cell
use
three
inhibitor
dynamin
inhibit
gtpase
activ
dynasor
block
lipid
bind
mitmab
three
inhibitor
affect
viru
replic
dynasor
mitmab
addit
file
ad
infect
even
import
effect
limit
ad
postinfect
addit
file
suggest
dynamin
import
earli
stage
infect
inhibitor
caus
mark
reduct
number
virion
enter
cell
figur
b
recent
xu
et
al
studi
jev
entri
cell
propos
new
modelactinand
dynamindepend
caveolaemedi
endocytosi
thu
analyz
effect
inhibit
rho
rock
kinas
viru
infect
inhibit
hamper
viral
replic
show
significantli
stronger
effect
present
prior
infect
control
control
addit
file
impli
involv
entri
process
result
far
suggest
crcov
enter
cell
via
caveolinand
dynamindepend
endocytosi
like
fusion
occur
earli
intern
therefor
examin
role
cytoskeleton
viru
entri
first
evalu
effect
actindisrupt
agent
cytochalasin
actin
stabil
compound
jasplakinolid
induc
microtubul
depolimer
nocodazol
addit
file
show
microtubul
import
viru
infect
actin
play
central
role
earli
stage
crcov
infect
disrupt
actin
filament
led
reduct
viral
infect
although
filament
stabil
effect
viru
yield
lack
effect
postentri
treatment
addit
file
impli
actin
requir
earli
event
crcov
infect
studi
viru
local
reveal
treatment
cytochalasin
multipl
viral
particl
local
actin
aggreg
figur
b
impli
intact
actin
cytoskeleton
play
role
intracellular
transport
virus
propag
virus
need
deliv
genet
materi
host
cell
envelop
virus
fuse
cellular
membran
prior
eject
genom
rna
dna
cytoplasm
may
take
place
cell
surfac
endocytosi
identifi
pathway
crcov
enter
human
epitheli
cell
first
ask
whether
crcov
enter
cell
via
endocytosi
sensit
lysosomotrop
agent
consid
good
evid
endocytosi
therefor
treat
cell
inhibitor
endosom
acidif
bafilomycin
ammonium
chlorid
compound
hamper
viru
infect
suggest
crcov
enter
cell
via
endocytosi
rather
via
direct
membran
fusion
howev
inhibitori
effect
inhibitor
alter
endosom
ph
observ
also
replic
stage
similar
phenomenon
previous
report
sarscov
suggest
compound
interfer
glycosyl
viral
protein
way
suppress
express
assembl
nonetheless
decid
present
data
viru
replic
supplementari
materi
focu
viru
entri
cell
singl
pathway
entri
report
coronavirida
inde
studi
identifi
clathrindepend
caveolindepend
clathrinandcaveolinindepend
endocytosisindepend
rout
see
tabl
identifi
rout
entri
use
crcov
util
inhibitor
sever
differ
pathway
see
addit
file
howev
worth
rememb
chemic
inhibitor
may
affect
phase
viru
replic
interf
viral
cellular
protein
eg
kinas
gtpase
inde
observ
nonspecif
interact
consequ
possibl
test
effect
chemic
inhibitor
viru
replic
viru
yield
reduc
almost
compound
affect
intracellular
traffick
address
issu
employ
complementari
approach
sirnamedi
knockdown
analysi
coloc
crcov
viral
particl
marker
differ
intracellular
compart
result
reveal
crcov
enter
cell
via
depend
pathway
inde
crcov
particl
coloc
endosom
coat
clathrin
endophilin
addit
file
furthermor
sirnamedi
deplet
inhibit
viru
entri
next
focus
dynamin
import
gtpase
involv
vesicl
scission
endocytosi
commonli
associ
clathrinmedi
endocytosi
also
play
role
phagocytosi
flotillindepend
endocytosi
use
three
dynamin
inhibitor
two
inhibit
gtpase
activ
one
block
lipidbind
domain
dynamin
result
led
us
conclud
crcov
entri
cell
dynamindepend
order
monitor
intracellular
traffick
crcov
determin
specif
point
viruscel
membran
fusion
examin
coloc
crcov
nucleocapsid
protein
endosom
vesicl
marker
result
show
crcov
present
earli
endosom
absent
late
recycl
endosom
lysosom
indic
fusion
crcov
cellular
membran
occur
earli
stage
endosom
recruit
rab
progress
late
phase
differ
major
coronavirus
travel
far
along
endocyt
pathway
access
high
cathepsin
activ
eg
sarscov
mhv
fipv
porcin
epidem
diarrhea
coronaviru
pathway
use
crcov
similar
use
merscov
report
util
furin
well
transmembran
proteas
serin
test
influenc
furin
inhibitor
decanoylrvkrchloromethyl
keton
order
studi
import
furin
crcov
entri
inhibit
viru
replic
cell
cell
spread
note
show
furin
process
relev
crcov
entri
one
may
howev
specul
regardless
fusion
host
membran
occur
earli
intern
crcov
may
still
util
cathepsin
similarli
coronavirus
even
cathepsin
consid
requir
acid
ph
activ
depend
vari
accord
substrat
far
substrat
describ
cleav
slightli
acid
ph
compar
achiev
endosom
matur
anoth
potenti
explan
cleavag
proteas
cell
surfac
recent
report
prefer
cathepsin
sever
coronavirus
last
object
studi
role
cytoskeleton
crcov
infect
discov
cell
treat
cytochalasin
prior
infect
viru
replic
reduc
entri
virion
accumul
actin
aggreg
surprisingli
anoth
actin
inhibitor
jasplakinolid
signific
effect
viru
replic
entri
interestingli
cytochalasin
jasplakinolid
affect
actin
cytoskeleton
via
oppos
mechan
cytochalasin
inhibit
polymer
actin
subunit
wherea
jasplakinolid
stabil
filament
inhibit
depolymer
result
obtain
use
two
agent
suggest
actin
filament
actin
reorgan
requir
crcov
entri
coronavirus
famili
virus
high
zoonot
potenti
present
real
threat
global
economi
public
health
show
crcov
reli
dynamindepend
figur
crcov
coloc
clathrin
opposit
alexa
fluor
conjug
transferrin
b
cell
treat
viru
transferrin
synchron
ice
min
incub
min
wash
fix
clathrin
hc
present
red
stain
viru
nucleocapsid
protein
green
c
neg
control
stain
coloc
chang
time
scale
bar
vesicl
scissiondynamin
depend
analysi
inhibitor
effect
crcov
entri
cell
pretreat
inhibitor
infect
presenc
incub
h
wash
fix
crcov
virion
present
green
blue
denot
dna
red
repres
actin
imag
singl
confoc
plane
b
repres
maximum
project
axial
plane
scale
bar
effect
cytoskeleton
reorgan
crcov
entri
analysi
inhibitor
effect
crcov
entri
cell
pretreat
inhibitor
infect
presenc
incub
h
wash
fix
crcov
virion
present
green
blue
denot
dna
red
repres
actin
imag
singl
confoc
plane
b
present
maximum
project
axial
plane
scale
bar
alpha
ph
depend
endocytosi
human
colon
adenocarcinoma
human
lung
caveolindepend
endocytosi
lipid
raft
mediat
human
primari
fibroblast
human
embryon
lung
cell
line
endocytosislaboratori
strain
membran
fusionclin
isol
human
cervix
hae
human
airway
epithelium
membran
fusion
hek
human
embryon
kidney
human
colon
adenocarcinoma
alpha
clathrindepend
endocytosi
rhesu
monkey
kidney
hae
human
airway
epithelium
felin
infecti
periton
alpha
clathrinand
caveolinindepend
endocytosi
primari
felin
monocyt
transmiss
gastroenter
viru
alpha
lipid
raft
mediat
st
swine
testicl
canin
enter
coronaviru
alpha
lipid
raft
mediat
canin
fibroma
mous
hepat
viru
beta
cell
membran
fusion
mous
fibroblast
ph
depend
endocytosi
murin
fibroblast
lipid
raft
mediat
dbt
cell
mous
astrocytoma
sarscov
beta
clathrindepend
endocytosi
human
hepatoma
membran
fusion
vero
african
green
monkey
kidney
lipid
raft
mediat
vero
african
green
monkey
kidney
clathrinand
caveolinindepend
endocytosi
hek
human
embryon
kidney
vero
african
green
monkey
kidney
membran
fusion
vero
african
green
monkey
kidney
hek
human
embryon
kidney
merscov
beta
viruscel
fusion
hek
human
embryon
kidney
human
colon
adenocarcinoma
beta
caveolindepend
endocytosi
human
adenocarcinoma
avian
infecti
bronchiti
viru
gamma
lowphdepend
viruscel
fusion
bhk
hamster
kidney
lipid
raft
mediat
vero
african
green
monkey
kidney
endocytosi
enter
host
cell
moreov
show
fusion
host
membran
occur
earli
intern
